Procalcitonin in Cirrhotic Patients at High Risk for Sepsis
NCT01578226
Ascites, Bacterial Infections
Modena, Italy
View Trial DetailsNCT Number: NCT07465003
Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study
Trial opening soon.
Get NotifiedAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline and 28 days.
Contact information is provided by the study sponsor or research team.
Li ShiYing Deputy Chief Physician of the Department of Infectious Disease, Ph.D
CONTACT
0086+18623322462
The Second Affiliated Hospital of Chongqing Medical University
Other
Use of Antimicrobial Drugs in Severe Infections and Epidemiological Study of Populations With Severe Infections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01578226
Ascites, Bacterial Infections
Modena, Italy
View Trial DetailsNCT00124228
Cirrhosis, Female Urogenital Diseases
Barcelona, Spain
View Trial DetailsNCT07668778
Bowel Preparation, Cirrhosis
Funchal, Madeira, Portugal
View Trial DetailsNCT07554183
Brain Diseases, Brain Diseases, Metabolic
Paris, France
View Trial Details